Human Papillomavirus (High Risk Only)
Use
The Aptima HPV assay is an in vitro nucleic acid amplification test for the qualitative detection of E6/E7 viral messenger RNA (mRNA) from 14 high-risk types of human papillomavirus (HPV) in cervical specimens. The high-risk HPV types detected by the assay include: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68.
Special Instructions
The test provides qualitative detection of E6/E7 mRNA from 14 high-risk HPV types. Storage requirements and specimen stability conditions should be adhered to ensure test accuracy.
Limitations
This assay is for the detection of E6/E7 viral mRNA from high-risk HPV types and may not detect all HPV infections. Insufficient specimen or low sample cellularity may result in a rejected specimen.
Methodology
Other (Transcription-Mediated Amplification)
Biomarkers
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Cervical Swab
Volume
2 mL
Minimum Volume
Not provided
Container
ThinPrep® or SurePath™
Storage Instructions
2°C to 30°C
Causes for Rejection
Insufficient specimen; Low sample cellularity
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | ThinPrep: 105 days (not above 8°C more than 30 days); SurePath: 21 Days |